Skip to main content

Suramin hemmt neben Tumorwachstum und Metastasierung auch die Angiogenese beim experimentellen Pankreaskarzinom

Suramin inhibits not only tumor growth and metastasis but also angiogenesis in experimental pancreatic cancer

  • Conference paper
Chirurgisches Forum 2004

Part of the book series: Deutsche Gesellschaft für Chirurgie ((FORUMBAND,volume 33))

  • 24 Accesses

Abstract

A previous study demonstrated that suramin reduces the proliferation of human pancreatic cancer cells in vitro and also reduces the secretion of the proangiogenic key factor VEGF This study examined the effect of suramin on tumor growth, metastasis and angiogenesis in vivo in an orthotopic nude mouse model.

1 mm3 fragments from 3 human pancreatic cancer cell lines (MIAPaCa-2, AsPC-1 and Capan 1) were orthotopically implanted in the pancreas of the nude mice. Volume of primary tumor, local infiltration, metastasis and microvascular density (MVD) were determined at autopsy. To assess the effect of suramin on angiogenesis, other tumor bearing animals were treated with a specific inhibitor of angiogenesis (TNP-470).

Suramin at low concentrations (10 mg/kg) had no influence on tumor growth, metastasis or angiogenesis in MIAPaCa-2 tumors. At high concentrations (60 mg/kg) Suramin reduced primary tumor growth and dissemination in all 3 pancreatic carcinomas. Suramin inhibited the MVD, but not as strong as the specific angiogenesis inhibitor TNP-470.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Literatur

  1. Porebski A, Hotz HG, Hotz B, Buhr HJ (2003) Suramin hemmt das Wachstum des humanen Pankreaskarzinoms in vitro und in vivo. Forum-Band 120. Kongress der DGCH

    Google Scholar 

  2. Hotz HG, Reber HA, Hotz B, Sanghavi PC, Yu T, Foitzik T, Buhr HJ, Hines OJ (2001) Angiogenesis inhibitor TNP-470 reduces human pancreatic cancer growth. J Gastrointest Surg. 5:131–138

    Article  PubMed  CAS  Google Scholar 

  3. Hotz HG, Reber HA, Hotz B, Yu T, Foitzik T, Buhr HJ, Cortina G, Hines OJ (2003) An orthotopic nude mouse model for evaluating pathophysiology and therapy of pancreatic cancer. Pancreas 26:E89–E98

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A. Porebski .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2004 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Porebski, A., Hotz, B., Buhr, H.J., Hotz, H.G. (2004). Suramin hemmt neben Tumorwachstum und Metastasierung auch die Angiogenese beim experimentellen Pankreaskarzinom. In: Ulrich, B., Jauch, KW., Bauer, H., Menger, M.D., Laschke, M., Slotta, J. (eds) Chirurgisches Forum 2004. Deutsche Gesellschaft für Chirurgie, vol 33. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-18547-2_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-18547-2_9

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-20027-7

  • Online ISBN: 978-3-642-18547-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics